跳至主要内容
临床试验/RBR-5ysgfv
RBR-5ysgfv招募中未知

Effect of coffee consumption on clinical variables, intestinal microbiota, oxidative stress and esteatose degree in patients with Non-Alcoholic Fatty Liver disease with or without polymorphism in gene PNPLA3

Instituto de Nutrição Josué de castro0 个研究点开始时间: 2019年8月26日最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 65Y(—)

入选标准

  • Patients diagnosed with non-alcoholic fatty liver disease through Fibroscam; both genders; aged between 18 and 65 years.

排除标准

  • Patients with: another cause of hepatic steatosis (alcohol, virus, genetics) or advanced liver disease; chronic kidney disease
  • thyroid diseases; cushing's syndrome; cancer; pregnant or lactating women; history of upper gastrointestinal surgery; use of medications for weight loss; report of sensitivity to coffee; consumption of more than 3 cups of coffee per day.

研究者

发起方
Instituto de Nutrição Josué de castro

相似试验

Effect of coffee consumption on patients with liver... | 临床试验